FDA Targets Generic Approvals, Drug Pricing for 2018

Drug Industry Daily
A A
Faster approvals of generics and biosimilars, along with other measures aimed at reducing prescription drug prices, will be ongoing FDA priorities in 2018.

To View This Article:

Login

Subscribe To Drug Industry Daily